Cite
HARVARD Citation
Remon, J. et al. (2017). CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies. Lung cancer. pp. 168-172. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Remon, J. et al. (2017). CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies. Lung cancer. pp. 168-172. [Online].